Abstract
The purpose of this study was to explore the feasibility of 11C-choline in the assessment of the degree of inflammation in atherosclerotic plaques. Methods: Uptake of 11C-choline was studied ex vivo in tissue samples and aortic sections excised from 6 atherosclerotic mice deficient for both low-density lipoprotein receptor and apolipoprotein B48 (LDLR−/−ApoB100/100) and 5 control mice. The autoradiographs were compared with the immunohistology of the arterial sites. Results: The uptake of 11C-choline (percentage of the injected activity per gram of tissue) in the atherosclerotic aortas of the LDLR−/−ApoB100/100 mice was significantly higher (1.9-fold, P = 0.0016) than that in the aortas of the control mice. The autoradiography analysis showed significantly higher uptake of 11C-choline in the plaques than in healthy vessel wall (mean ratio, 2.3 ± 0.6; P = 0.014), prominently in inflamed plaques, compared with noninflamed plaque areas. Conclusion: We observed a high 11C-choline uptake in the aortic plaques of atherosclerotic mice. Our data suggest that macrophages may be responsible for the uptake of 11C-choline in the plaques.
Atherosclerotic plaque rupture is a major cause of acute cardiac events and stroke. Conventional anatomic imaging may not provide sufficient information for the risk assessment; therefore, the detection and identification of rupture-prone atherosclerotic plaques remains a great clinical challenge. Inflammation and metabolic activity of the plaque are considered key features in terms of plaque vulnerability. High concentrations of inflammatory cells, mainly macrophages, have been demonstrated to be typical of vulnerable plaques (1,2). In addition to inflammation, cell proliferation has also been suggested to play an important role in the progression of atherosclerotic plaques, with monocytes or macrophages being the main proliferative cell type in the intimae of human plaques (3). Noninvasive imaging of inflammation, together with the possible detection of proliferative cells within atherosclerotic lesions, may be a useful approach for the purpose of predicting future risk of plaque rupture.
Radiolabeled choline and choline analogs have been used in the imaging of various cancer types (4). Choline is a source for cell membrane lipids, and all the nucleated cells have specific choline transport mechanisms, varying in expression and being highest in the proliferative cells. Phosphorylated by choline kinase, choline eventually incorporates into cell membranes. Increased choline transport and choline kinase activity in tumor cells and macrophages have been suggested to result in increased choline uptake in these cells (5,6).
A recent study demonstrated 18F-fluorocholine uptake in atherosclerotic lesions in a mouse model, with a positive correlation to macrophage staining (7). 18F-fluorocholine and 11C-choline have been shown to visualize the vessel wall alterations in the aorta and carotid arteries in cancer patients (8,9). The radioactivity was found mainly in the noncalcified vessel wall areas of elderly prostate cancer patients. Without any histologic evidence, however, the true nature of these vessel wall alterations remains unknown, and therefore, further studies are required to establish the uptake of radiolabeled choline in different types of plaques.
The purpose of this study was to explore the feasibility of 11C-choline in the assessment of the degree of inflammation in atherosclerotic plaques using an atherosclerotic mouse model.
MATERIALS AND METHODS
Animals
At the age of 15 mo, male mice deficient for both low-density lipoprotein receptor and apolipoprotein B48 (LDLR−/−ApoB100/100) (strain 003000; Jackson Laboratory) were fed for 2 mo with a Western-type diet (TD.88137, Adjusted Calories Diet; Harlan). The normally fed male control mice (C57BL) were 13 ± 2 mo old. The study design was approved by the Laboratory Animal Care and Use Committee of the University of Turku, Finland.
Synthesis of 11C-Choline
11C-Choline was produced through the reaction of N,N-dimethyl-2-aminoethanol and 11C-methyl triflate using high-performance liquid chromatography purification and analysis procedures described by Rosen et al. (10), with high radiochemical yield (>70%) and radiochemical purity (>99.5%).
Biodistribution and Blood Metabolism of 11C-Choline in Atherosclerotic and Control Mice
Six atherosclerotic LDLR−/−ApoB100/100 mice (mean weight ± SD, 38 ± 3 g) and 5 C57BL control mice (42 ± 6 g) were intravenously injected with 11C-choline (27 ± 10 MBq) via the tail, and after 10 min, the animals were sacrificed under isoflurane anesthesia. Samples of whole blood and tissues (Table 1) were dissected, weighed, and measured for radioactivity using an automatic γ-counter (1480 Wizard 3″; EG&G Wallac). The data were corrected for background and decay. The radioactivity that had accumulated in the tissues was expressed as a percentage of the injected activity per gram of tissue. The plasma was further analyzed for radiometabolites as described earlier (11).
Autoradiographic Analysis of 11C-Choline in Aortic Cryosections
The distribution of 11C-choline to the aortic tissue was studied with digital autoradiography as described before (12). Briefly, after 1 h of exposure the imaging plates were scanned (Imaging Plate BAS-TR2025 [Fuji]; Analyzer BAS-5000 [Fuji]), and the images of aortic sections were analyzed for count densities (photostimulating luminescence units [PSL]/mm2) with an image-analysis program (Tina 2.1; Raytest Isotopenmessgeräte GmbH). Three types of regions of interest (ROIs) were defined according to the histology: plaque (excluding the medium), adventitia (containing the adjacent adipose tissue), and healthy vessel wall (Figs. 1A and 1B). The background count densities were subtracted from the image data. ROIs for all visible plaques were drawn over the areas where the plaque was easily identifiable.
Histology and Immunohistochemistry
After autoradiography, the 20-μm sections were stained with hematoxylin and eosin and studied for morphology under a light microscope. Consecutive 8-μm sections were immunostained with Mac-3 (clone M3/84; BD Pharmingen) or Ki-67 (clone Mib-1; Dako) for the detection of macrophages and proliferating cells, respectively.
Randomly selected plaque areas (n = 35) were semiquantitatively assessed for the degree of inflammation by estimating the number of nuclei and Mac-3–positive cells in consecutive sections, without knowledge of the corresponding autoradiography results. The ROIs in these plaques were divided into 2 categories: noninflamed, with none or occasional leukocytes in the region, and inflamed, with a high number of nuclei and corresponding Mac-3 staining in the area.
Statistical Methods
All the results are expressed as the mean ± SD. Student t test for nonpaired data and Dunnett test were used to compare the biodistribution of 11C-choline in organs. Univariate correlations were calculated using the Pearson partial-correlation method. Repeated-measures ANOVA with Tukey correction was applied to the autoradiography data. Normality was tested using the Shapiro–Wilkins method. A P value less than 0.05 was considered as statistically significant.
RESULTS
Characterization of Atherosclerotic Plaques
All of the studied LDLR−/−ApoB100/100 mice had developed extensive atherosclerosis throughout the aorta. The observed plaques in the aortas of the LDLR−/−ApoB100/100 mice contained cell-rich, inflamed areas and acellular necrotic cores. Occasional calcifications were also found. Mac-3 staining revealed areas in the plaques with a moderate number of macrophages (Fig. 1C). Only a few Ki-67–positive cells were detected in the plaques (Fig. 1D).
Ex Vivo Biodistribution and Blood Metabolism of 11C-Choline
The 11C radioactivity measured at 10 min after the injection of 11C-choline was 1.9-fold higher in the aortas of the LDLR−/−ApoB100/100 mice than those of the C57BL control mice (n = 6 and 5, respectively, P = 0.0016) (Table 1). In the other measured tissues, no significant differences between the atherosclerotic and the control mice were observed. The 11C radioactivity was highest in kidneys, lung, heart, and liver (Table 1). The aorta-to-blood and aorta-to-muscle ratios of the LDLR−/−ApoB100/100 mice were 5.5 ± 2.2 and 3.0 ± 0.9, respectively. The biodistribution of 11C-choline in the circulating blood was not affected by the animal weight or strain (P = 0.08).
The high-performance liquid chromatography radiodetector analysis of the mouse plasma samples (n = 6) revealed 15% ± 7% of unchanged 11C-choline at 10 min after injection. The percentages of total radioactivity were 78% ± 7% for 11C-betaine and 9% ± 3% for another radiometabolite (unidentified).
Autoradiography of Aortic Cryosections
Hematoxylin and eosin–stained longitudinal cryosections throughout the aorta (n = 6–7 sections of each animal) were imaged under a light microscope, and the images were combined with the autoradiographs to define ROIs. The mean uptake of 11C radioactivity in each region was calculated for each mouse (Table 2).
The autoradiography analysis showed a significant uptake of 11C radioactivity in the plaques in comparison to the healthy vessel wall (plaque-to-wall ratio, 2.3 ± 0.6; P = 0.014, n = 6 LDLR−/−ApoB100/100 mice). The adjacent adventitial tissue, containing the adipose tissue surrounding the vessel, also showed a substantial uptake (adventitia-to-wall ratio, 1.9 ± 0.5; P = 0.016), which, however, was significantly lower than that in the plaques (P = 0.021). No significant uptake was found in calcifications.
The mean plaque-to-wall ratios were 2.6 ± 0.8 and 1.4 ± 0.5 in inflamed and noninflamed plaques, respectively (P < 0.001) (Fig. 2). Most of the cells in the inflamed plaques were identified as macrophages.
DISCUSSION
Our results revealed a significantly higher uptake of 11C-choline in inflamed atherosclerotic plaques than in healthy vessel wall in LDLR−/−ApoB100/100 mice. According to autoradiography and ex vivo biodistribution analyses, both the plaque-to-wall ratio and the aorta-to-blood ratio were reasonably high, suggesting the tracer's potential for in vivo PET.
Choline uptake may be amplified either by enhanced transport or by increased choline kinase activity, for example, in cancer cells. In addition to cancer imaging, choline-derived tracers have shown potential for inflammation imaging and accumulation in inflammatory cells (5,13). The metabolic activity and the production of nitric oxide may explain the choline uptake in macrophages (14), but this requires further study.
Our study showed a 1.9-fold higher uptake of 11C-choline in the aortas of the atherosclerotic mice than in the aortas of the control mice. Our biodistribution results are in accordance with the results of previous studies (15–17). At 10 min after injection, the target-to-background (aorta-to-blood) ratio was 5.5, indicating fast blood clearance. We observed high uptake in the heart and kidneys, which could be problematic when imaging these targets. However, there seems to be a species difference, because low myocardial uptake has been previously reported in humans (7,9). Choline and its metabolites such as betaine or acetylcholine may have a different cardiac uptake pattern in rodents.
The autoradiography analysis revealed 2.3-fold higher uptake in plaques in general and 2.6-fold higher uptake in the inflamed plaques than the healthy vessel wall. In noninflamed plaques, the plaque–to–normal wall ratio was significantly lower, suggesting that inflammatory cells, mainly macrophages, may be the reason for increased uptake. Relatively high uptake in adventitia requires further study but is likely due to resident macrophages and possibly to infiltrated leukocytes.
Previously, for 18F-fluorocholine, a plaque–to–normal wall ratio of nearly 5 was reported in ApoE−/− mice (7) (achieved using an en face autoradiography method). Microautoradiography of the aortic sections, which is comparable to the method used in this study, revealed a plaque-to-wall ratio of 3.5. However, 11C-choline and 18F-fluorocholine are 2 different compounds with divergent pharmacokinetic properties; thus, no direct comparison can be made.
Choline uptake has been previously shown to correlate with proliferative activity in the tissue (6). However, the overall proliferative activity in the plaques was low, only 0.49% (18). In our study, only a few Ki-67–positive cells were found in the plaques, and this cannot explain the found uptake.
Although we found a significant difference between the biodistribution of 11C-choline to the atherosclerotic and the healthy aortas, we used only a limited number of animals in this study. However, the autoradiography analysis was performed in multiple sections covering all the plaques to better estimate the distribution to different plaques. The analysis also showed that the uptake varied depending on the plaque morphology.
CONCLUSION
We observed that 11C-choline uptake in the atherosclerotic plaques was significantly increased as compared with the healthy vessel wall. Our findings suggest that macrophages may be responsible for the higher uptake of 11C-choline in the plaques. Although uptake of 11C-choline was prominent in the atherosclerotic plaques in this animal model, further clinical studies are needed to elucidate the value of 11C-choline as a marker of plaque inflammation for in vivo imaging.
Acknowledgments
We thank Erica Nyman for technical assistance and Irina Lisinen for statistical analysis. This work was funded by the Instrumentarium Foundation, Finnish Cultural Foundation, Turku University Foundation, Academy of Finland (no. 119048), Hospital District of Southwest Finland, and Drug Discovery Graduate School. The study was conducted within the Finnish Centre of Excellence in Molecular Imaging in Cardiovascular and Metabolic Research, which is supported by the Academy of Finland, University of Turku, Turku University Hospital, and Åbo Akademi University.
Footnotes
-
COPYRIGHT © 2010 by the Society of Nuclear Medicine, Inc.
References
- Received for publication October 21, 2009.
- Accepted for publication February 2, 2010.